regenerative medicine

A groundbreaking study published in the journal Aging (Aging-US) on February 18, 2025, explores the potential of platelet-rich plasma (PRP) in improving ovarian function and enhancing egg quality in women with diminished ovarian reserve. The study, conducted by researchers from IVIRMA New Jersey, Yale School of Medicine, Yale University, and Acibadem Mehmet Ali Aydinlar University, offers hope to women struggling with infertility and poor ovarian response (POR) during in vitro fertilization (IVF) treatment.

A groundbreaking advancement in cardiac surgery could soon transform the way doctors perform vascular bypass procedures. Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have successfully developed an off-the-shelf, stem cell-based vascular graft that could significantly improve outcomes for patients requiring bypass surgery.

This blog post discusses the groundbreaking collaboration between Aston University and the Royal Orthopaedic Hospital in developing an innovative injectable paste for bone cancer treatment. The research focuses on using gallium-doped bioglass to enhance therapeutic efficacy while minimizing side effects. By delivering targeted therapy directly to tumor sites, this advancement aims to improve patient outcomes, reduce recurrence rates, and expedite recovery times. This interdisciplinary effort symbolizes a significant leap in oncology care, offering hope for better treatment solutions and improved quality of life for bone cancer patients.